Application of Time-To-Event Methods in the Assessment of Safety in Clinical Trials

Chapman & Hall/CRC Biostatistics Series
doi 10.1201/9781420066401.ch20
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Chapman and Hall/CRC

Related search

Assessment of Proportional Hazard Assumption in Aggregate Data: A Systematic Review on Statistical Methodology in Clinical Trials Using Time-To-Event Endpoint

British Journal of Cancer
Cancer ResearchOncology
2018English

Critical Design Considerations for Time-To-Event Endpoints in Amyotrophic Lateral Sclerosis Clinical Trials

Journal of Neurology, Neurosurgery and Psychiatry
PsychiatryMental HealthNeurologySurgery
2019English

Sample Size Formula for Joint Modelling of Longitudinal and Time-To-Event Data in Clinical Trials

Trials
MedicinePharmacology
2013English

Adjustment for Treatment Changes in Epilepsy Trials: A Comparison of Causal Methods for Time-To-Event Outcomes

Statistical Methods in Medical Research
Health Information ManagementEpidemiologyStatisticsProbability
2017English

Modelling Seizure Rates Rather Than Time to an Event Within Clinical Trials of Antiepileptic Drugs

BMC Medical Research Methodology
EpidemiologyHealth Informatics
2020English

Statistical Test/Estimation Methods Used in Contemporary Phase III Cancer Randomized Controlled Trials With Time‐to‐Event Outcomes

Oncologist
Cancer ResearchMedicineOncology
2019English

Adverse Event Reporting in Clinical Trials of Finasteride for Androgenic Alopecia

JAMA Dermatology
DermatologyMedicine
2015English

Meta-Analysis of Safety for Low Event-Rate Binomial Trials

Research Synthesis Methods
Education
2012English

Time to Welcome the Elderly Into Clinical Trials

Nature Clinical Practice Cardiovascular Medicine
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy